Anti-alpha-gal antibody (Anti-Gal)

Anti-alpha-gal antibodies are naturally occurring immunoglobulins (primarily IgM, IgG, and IgA, but in some allergic contexts IgE) present in humans and some primates. These antibodies are directed against the alpha-gal epitope (galactose-α-1,3-galactose) found in non-primate mammals, certain parasites, and some foods. While these antibodies are protective against zoonoses and play roles in xenograft rejection, when class-switched to IgE in certain individuals (commonly after tick bites), they can cause severe allergic reactions upon exposure to alpha-gal-containing products. This underlies alpha-gal syndrome (red meat allergy), hypersensitivity to some biologic drugs (e.g., cetuximab), and possibly impacts wound healing and vaccine responses by facilitating immune recognition of alpha-gal-containing therapeutics[2][1][5][6][7]. **Notes on structured extraction:** - The query refers to "Pre-existing natural anti-alpha-gal antibodies" as a potential *therapeutic target*, but scientific convention considers these **antibodies** to be *effectors* or *mediators* of immune phenomena, not canonical therapeutic targets like receptors or enzymes. - The correct canonical name is "Anti-alpha-gal antibody" (not the plural or phrase). - The entry is flagged **is_incorrect: true** because it refers to an immunological entity (antibody) rather than a receptor, enzyme, or canonical drug target; also, the term is awkwardly phrased and redundant. - Natural anti-alpha-gal antibodies are not “targeted” by therapeutics; rather, their presence is clinically relevant for risk stratification (biomarker) and in understanding immune responses[2][1][10]. **If you want information about the actual antigen (the target of the antibodies), you should refer to “Alpha-gal epitope” (galactose-α-1,3-galactose).**

Other names

Anti-Gal antibodyanti-alpha-galanti-Gal immunoglobulin

For cetuximab: Hypersensitivity is triggered by pre-existing anti-alpha-gal IgE binding to alpha-gal epitopes on the drug